In the next study conducted by the same group, five patients with active SLE were treated with autologous anti-CD19 CAR-T cells (single infusion at dose of 1 × 106 CAR-T cells per kg body weight) [44]. The gene discussed is CD19; the disease is systemic lupus erythematosus.